Sunnymeath Asset Management’s Celgene Corp CELG Stock Holding History

Sunnymeath Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.66M	Buy	14,325 +800	+6%	+$89.1K	2.33%	7
2016 Q3	$638K	Sell	13,525 -1,800	-12%	-$195K	1.4%	30
2016 Q2	$1.53M	Hold	15,325	–	–	2.24%	7
2016 Q1	$1.54M	Sell	15,325 -75	-0.5%	-$7.72K	2.36%	6
2015 Q4	$1.84M	Buy	+15,400	New	+$1.78M	2.94%	2

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sunnymeath Asset Management's CELG Position: Q4 2016 in Review

Sunnymeath Asset Management increased its Celgene Corp (CELG) stake by 5.9% in Q4 2016, buying an estimated $89.1K and bringing the position to 14,325 shares worth $1.66M. The position accounts for 2.33% of the portfolio, ranked #7.

Sunnymeath Asset Management first reported a position in CELG in Q4 2015 and has held it in 5 quarters since. The position peaked at $1.84M in Q4 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

Sunnymeath Asset Management held 14,325 shares of Celgene Corp worth $1.66M as of Q4 2016.
Sunnymeath Asset Management bought 800 Celgene Corp shares in Q4 2016, an estimated $89.1K.
Celgene Corp made up 2.33% of Sunnymeath Asset Management's portfolio in Q4 2016, its #7 holding.
Sunnymeath Asset Management first reported a position in Celgene Corp in Q4 2015 and has held it in 5 quarters since.
Sunnymeath Asset Management's Celgene Corp position peaked at $1.84M in Q4 2015.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.